Lilly shareholders are set to gather Monday in Indianapolis to hear an update on the company’s performance, including
how it will keep paying its generous dividend during the lean years after Zyprexa’s patent expiration.
The Indianapolis-based drugmaker also lowered its forecast for full-year profits because the new health care law grants bigger
rebates on prescription drugs to federal health insurance programs.
As shareholders gather April 19 for Eli Lilly and Co.’s annual meeting, more of them than ever will come with an unusual question:
Will Lilly be able to keep paying its dividend?
Clarian Health is planning to build a bed tower at Methodist Hospital in a massive project that shows renewed
commitment
to the downtown campus. The tower would have 175 to 250 beds and allow Methodist to make all its rooms private.
Conseco expects its write-offs will be worth more than $800 million over the next 20 years.
Indianapolis-based WellPoint “reclassified” more than half a billion dollars of administrative expenses as medical
expenses when it was defining its medical-loss ratio, according to a report released by U.S. Senator Jay Rockefeller’s
office.
State insurance officials are warning Indiana residents about questionable health insurance policies being offered by companies
touting themselves as associations.
Eighteen states, including Indiana, argue the federal government cannot force citizens to buy health insurance coverage.
Jim Parker was an executive at Anthem Blue Cross and Blue Shield and WellPoint for 14 years, including a year and a half as
chief of staff to CEO Angela Braly. He now is president of his own consulting firm, Meridian Strategic Advisors, in Indianapolis.
He spoke about the impact of the new health reform law on health insurers.
Employers are still trying to get their arms around what the new health insurance law will mean for them. But on the eve of
the law's passage last month, a survey by Indianapolis-based United Benefit Advisors LLC showed employers as a group had
no hope the law would reduce their costs but also no coherent plan for reforming the current system.
In poll after poll, calls for repealing the new health insurance law get strong support. But if the law were repealed, an
Indiana University survey released this week shows that Americans want a surprising thing in its place: a public option.
A U.S. mandate forcing insurers led by UnitedHealth Group Inc. and WellPoint Inc. to spend 85 percent of revenue from premiums
on medical care is the newest front in the battle between the Obama administration and companies over industry profits.
Stimulus dollars from the National Institutes of Health expected to spark 30 to 40 new research jobs by 2013.
As IBJ reported last year, Houston-based American General Life Insurance Company is attempting to invalidate a $15
million policy it issued in January 2006 insuring the life of Germaine “Suzy” Tomlinson—Conseco Inc. co-founder
Stephen Hilbert’s mother-in-law—who died Sept. 28, 2008, at age 74.
Work force reductions, new business structure make leased office space unnecessary. Moves will begin in late June.
Once-weekly form of Byetta is awaiting the FDA’s OK. Analyst predict the new version of the drug, if approved, could rack
up sales of $2 billion annually.
The Indiana Health Care Association is looking for a new leader even as it tries to dig out of a pile
of debt. Current President Steve Smith, whose contract expires Nov. 30, says he’s put the organization on a path to be financially stable by 2012. But his predecessor says Smith has ruined a once-strong organization.
Louisiana was one of 13 states that filed individual suits in state courts over allegations that Lilly pushed Zyprexa for
uses that had not been approved by federal regulators.
Anthem Blue Cross and Blue Shield of Indiana fell slightly below average for customer satisfaction among scores of health
plans,
according to a new survey by California-based J.D. Power & Associates.
Relocating operations to an existing plant in Canton, Ga., will result in the loss of 130 jobs.
